MedPath
TGA Approval

Hospira MitoXANTRONE Injection, USP (concentrate) 25 mg/12.5 mL vial (143488)

143488

Hospira MitoXANTRONE Injection, USP (concentrate) 25 mg/12.5 mL vial

Hospira Australia Pty Ltd

August 20, 2007

Medicine

Medicine

Active

Listed - Exempt

Active Ingredients

mitoxantrone (mitozantrone) hydrochloride

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Hospira MitoXANTRONE Injection, USP (concentrate) 25 mg/12.5 mL vial (143488) - TGA 批准文号 | MedPath